Use of peptide epoxyketones for metastasis suppression
US8853147B2 · kind B2 · utility
8Cited by
71References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 11, 2010 |
| Grant date | Oct 7, 2014 |
| Priority date | — |
| Expiry date | Nov 11, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a method of repressing metastasis of a cancer compromising the administration of a peptide epoxyketone proteasome inhibitor. Furthermore, the method can be performed in combination with the administration of one or more additional therapeutics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.